Zhu et al. found that RAB35 expression increased in MCF-7 breast cancer cells, and significantly inhibited Wnt5a-induced cell proliferation after knocking down RAB35 expression A study showed that RAB35 was abnormally highly expressed in breast cancer cells MCF-7, and when RAB35 expression was inhibited, Wnt5a induced cell proliferation was also inhibited [20]. The gene discussed is WNT5A; the disease is breast carcinoma.